Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis

被引:1
作者
Marques, Paula Teixeira [1 ]
Kay, Claudia Suemi Kamoi [1 ]
Basilio, Flavia Machado Alves [2 ]
Pinheiro, Rosangela Lameira [3 ]
Werneck, Lineu Cesar [1 ]
Lorenzoni, Paulo Jose [1 ]
Scola, Rosana Herminia [1 ]
机构
[1] Univ Fed Parana UFPR, Hosp Clin, Dept Internal Med, Dept Neurol, Curitiba, Parana, Brazil
[2] Univ Fed Parana UFPR, Hosp Clin, Dept Internal Med, Dept Dermatol, Curitiba, Parana, Brazil
[3] Univ Fed Parana UFPR, Hosp Clin, Mycol Lab, Curitiba, Parana, Brazil
关键词
EPIDEMIOLOGY; CELL;
D O I
10.1016/j.msard.2020.102029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页数:2
相关论文
共 12 条
  • [1] Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
    Bornsen, Lars
    Christensen, Jeppe Romme
    Ratzer, Rikke
    Oturai, Annette Bang
    Sorensen, Per Soelberg
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    [J]. PLOS ONE, 2012, 7 (11):
  • [2] CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients
    Carotenuto, Antonio
    Scalia, Giulia
    Ausiello, Francesco
    Moccia, Marcello
    Russo, Cinzia Valeria
    Sacca, Francesco
    De Rosa, Anna
    Criscuolo, Chiara
    Del Vecchio, Luigi
    Morra, Vincenzo Brescia
    Lanzillo, Roberta
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2017, 309 : 47 - 50
  • [3] Global epidemiology of sporotrichosis
    Chakrabarti, Arunaloke
    Bonifaz, Alexandro
    Gutierrez-Galhardo, Maria Clara
    Mochizuki, Takashi
    Li, Shanshan
    [J]. MEDICAL MYCOLOGY, 2015, 53 (01) : 3 - 14
  • [4] New fungal infections associated with disease-modifying treatments in MS
    Correale, Jorge
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (07) : 1004 - 1006
  • [5] Natalizumab adverse events are rare in patients with multiple sclerosis
    Fragoso, Yara Dadalti
    Alves-Leon, Soniza Vieira
    Arruda, Walter Oleschko
    Carvalho, Margarete de Jesus
    Comini-Frota, Elizabeth Regina
    Correa, Eber Castro
    Brito Ferreira, Maria Lucia
    da Gama, Paulo Diniz
    Gomes, Sidney
    Magno Goncalves, Marcus Vinicius
    Kaimen-Maciel, Damacio Ramon
    Mendes, Maria Fernando
    Morales, Rogerio Rizo
    Muniz, Andre
    Salgado, Pedro Rippel
    Ruocco, Heloisa Helena
    Bezerra de Albuquerque, Livia Brito
    Bidin Brooks, Joseph Bruno
    Fezer, Leticia
    Georgetto, Sergio
    Lopes, Josiane
    Malfetano, Fabiola Rachid
    Meira, Isabella D'Andrea
    Silva Oliveira, Celso Luis
    Meneses de Oliveira, Francisco Tomaz
    Safanelli, Fabiana
    Satomi, Massaco
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (03) : 137 - 141
  • [6] Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
    Kappos, Ludwig
    Bates, David
    Edan, Gilles
    Eraksoy, Mefkure
    Garcia-Merino, Antonio
    Grigoriadis, Nikolaos
    Hartung, Hans-Peter
    Havrdova, Eva
    Hillert, Jan
    Hohlfeld, Reinhard
    Kremenchutzky, Marcelo
    Lyon-Caen, Olivier
    Miller, Ariel
    Pozzilli, Carlo
    Ravnborg, Mads
    Saida, Takahiko
    Sindic, Christian
    Vass, Karl
    Clifford, David B.
    Hauser, Stephen
    Major, Eugene O.
    O'Connor, Paul W.
    Weiner, Howard L.
    Clanet, Michel
    Gold, Ralf
    Hirsch, Hans H.
    Radue, Ernst-Wilhelm
    Sorensen, Per Soelberg
    King, John
    [J]. LANCET NEUROLOGY, 2011, 10 (08) : 745 - 758
  • [7] Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
    Luna, Gustavo
    Alping, Peter
    Burman, Joachim
    Fink, Katharina
    Fogdell-Hahn, Anna
    Gunnarsson, Martin
    Hillert, Jan
    Langer-Gould, Annette
    Lycke, Jan
    Nilsson, Petra
    Salzer, Jonatan
    Svenningsson, Anders
    Vrethem, Magnus
    Olsson, Tomas
    Piehl, Fredrik
    Frisell, Thomas
    [J]. JAMA NEUROLOGY, 2020, 77 (02) : 184 - 191
  • [8] A controlled trial of natalizumab for relapsing multiple sclerosis.
    Miller, DH
    Khan, OA
    Sheremata, WA
    Blumhardt, LD
    Rice, GPA
    Libonati, MA
    Willmer-Hulme, AJ
    Dalton, CM
    Miszkiel, KA
    O'Connor, PW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) : 15 - 23
  • [9] Natalizumab effects on immune cell responses in multiple sclerosis
    Niino, M
    Bodner, C
    Simard, ML
    Alatab, S
    Gano, D
    Kim, HJ
    Trigueiro, M
    Racicot, D
    Guérette, C
    Antel, JP
    Fournier, A
    Grand'Maison, F
    Bar-Or, A
    [J]. ANNALS OF NEUROLOGY, 2006, 59 (05) : 748 - 754
  • [10] Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics
    Orofino-Costa, Rosane
    de Macedo, Priscila Marques
    Rodrigues, Anderson Messias
    Bernardes-Engemann, Andrea Reis
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (05) : 606 - 618